French One Day Survey in 2011 - Knowing Our Population of Labile Blood Products Recipients (PopReceveur)

October 17, 2017 updated by: Etablissement Français du Sang

French Transfusion Recipients Cross Sectional Study : Get to Know the Transfusion Recipients Population

Describe the epidemiologic profile and clinical context of transfusion recipients in France. Describe the clinical context of transfusion.

Describe the characteristics of the transfusion prescriptions, the use of blood products and the main indications for transfusion.

Describe transfusion practice according the type of hospital stay.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

4720

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

french population of recipients

Description

Inclusion Criteria:

• Transfusion with at least one blood product on the day of the study.

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Blood product recipients
All patients who received at least one blood product on the day of the study
Procedure: Transfusion of blood products

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of red blood cell concentrates received
Time Frame: 1 day (cross sectional)
transversal study
1 day (cross sectional)
Number of platelet concentrates recevied
Time Frame: 1 day (cross sectional)
transversal study
1 day (cross sectional)
Number of plasma units received
Time Frame: 1 day (cross sectional)
transversal study
1 day (cross sectional)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Etablissement Français du Sang

Collaborators

Assistance Publique Hopitaux De Marseille
Centre Hospitalier Universitaire de Nice
Centre Hospitalier Universitaire de Besancon
Région Nord-Pas de Calais, France

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2011

Primary Completion (Actual)

November 1, 2011

Study Completion (Actual)

December 1, 2011

Study Registration Dates

First Submitted

September 29, 2017

First Submitted That Met QC Criteria

October 17, 2017

First Posted (Actual)

October 18, 2017

Study Record Updates

Last Update Posted (Actual)

October 18, 2017

Last Update Submitted That Met QC Criteria

October 17, 2017

Last Verified

October 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EFS/2011/PopReceveur

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hematologic Diseases

Clinical Trials on Transfusion of blood products

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe